Company Data
ImmunityBio Inc.
Ticker
IBRX
Current Price
$3.42 -6.04%
Market Cap
$2.4B
Price Target
Refer to Report
Volume
5.2M
52wk Range
$2.28 - $10.53
Overview
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company’s immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.